Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

232.75
-1.8100-0.77%
Post-market: 235.002.25+0.97%19:41 EDT
Volume:796.45K
Turnover:185.00M
Market Cap:30.13B
PE:-106.81
High:237.77
Open:230.36
Low:228.28
Close:234.56
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-ACNB, Carnival Corp, Boeing

Reuters
·
21 Mar

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue?

Zacks
·
21 Mar

Alnylam Pharmaceuticals Shares up 4% After FDA Expands Approval for Drug to Treat Rare Heart Disease

THOMSON REUTERS
·
21 Mar

Alnylam Pharmaceuticals Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
21 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Microchip Technology, IAC, Micron Technology

Reuters
·
21 Mar

Sector Update: Health Care Stocks Steady Premarket Friday

MT Newswires Live
·
21 Mar

RBC Adjusts Price Target on Alnylam Pharmaceuticals to $330 From $310, Maintains Outperform Rating

MT Newswires Live
·
21 Mar

Alnylam Pharma (ALNY) Initiated with a Hold at Cantor Fitzgerald

TIPRANKS
·
21 Mar

Alnylam Pharma (ALNY) Gets a Buy from Chardan Capital

TIPRANKS
·
21 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Cowell, Nike, Alnylam Pharma

Reuters
·
21 Mar

Alnylam's Amvuttra Seen as Mega Blockbuster -- Market Talk

Dow Jones
·
21 Mar

Alnylam shares rise on expanded heart drug approval

Reuters
·
21 Mar

Alnylam Pharmaceuticals Inc : Wells Fargo Raises Target Price to $287 From $275

THOMSON REUTERS
·
21 Mar

Alnylam Pharmaceuticals Price Target Maintained With a $320.00/Share by Needham

Dow Jones
·
21 Mar

Alnylam Pharmaceuticals Inc : Leerink Partners Raises Target Price to $206 From $200

THOMSON REUTERS
·
21 Mar

BUZZ-Alnylam zooms as FDA expands approval of rare heart disease drug

Reuters
·
21 Mar

Alnylam Pharmaceuticals Shares up About 7% Premarket After FDA Expands Approval for Drug to Treat Rare Heart Disease

THOMSON REUTERS
·
21 Mar

Alnylam Pharmaceuticals Inc : Scotiabank Raises Target Price to $338 From $300

THOMSON REUTERS
·
21 Mar

Alnylam Pharmaceuticals Inc : Citigroup Raises Target Price to $351 From $338

THOMSON REUTERS
·
21 Mar

Alnylam Pharmaceuticals Recieives US FDA Approval for ATTR-CM Drug

MT Newswires Live
·
21 Mar